eli lilly glp 1 drugs Ground News | Federal regulators approved Lilly's new weight-loss pill, orforglipron, giving patients a second daily oral GLP-1 treatment for obesity FDA approves Foundayo, an oral
Description
Theranostics 13 (6), 17741808
Sinclair, Alex Evaluation of cognitive performance with medicines for raised intracranial pressure: implications for spaceflight associated neuro-ocular syndrome [abstract]
Early studies show up to 13% body weight reduction in three months
doi: 10.1210/mend-3-6-1014
